The prognostic factors and analysis of adjuvant chemotherapy for high risk upper tract urothelial carcinoma

杜智勇,秦川,申忠华,陈斐然,唐刚,田大伟,胡海龙,吴长利

DOI: https://doi.org/10.3760/cma.j.issn.1000-6702.2016.11.004

2016-01-01

Abstract:Objective To evaluate the prognostic factors and the effect of adjuvant chemotherapy for T3/T4 (N0/N+) upper tract urothelial carcinoma (UTUC).Methods 92 cases of UTUC and clinical follow-up data from September 2011 to February 2016 were analyzed retrospectively.All patients underwent radical surgery and analyzed pathological examination for all surgical specimens.There was 92 cases of T3/T4(No/N+)UTUC,54 males and female;age were from 44 to 94 years,mean age was 67 years;tumor size were 1-8cm,mean size was 3.6cm.47 cases (51％)received adjuvant chemotherapy.These patients were divided into 2 groups which depend whether patents received adjuvant chemotherapy or not.Cohorts were stratified by gender,age,performance status,tumor number,size,grade and stage.The chi-square test was used to examine the relationship among the various cohorts and the receipt of adjuvant chemotherapy.Cox proportional hazard modeling and Kaplan-Meier analysis were used to determine overall and cancer specific survival in the cohort.Results The median follow-up time was 24(range:4-52)months,and during followup,21 cases(22.8％)were died for cancer,5 cases(5.4％) were died for other reasons.There was no significant difference in overall or cancer specific survival between patients who did and did not receive adjuvant chemotherapy (P ＞ 0.05).However performance state (P =0.011,P =0.034) and tumor stage (P =0.018,P =0.010) were significant predictors of overall and cancer specific survival.Conclusions This finding suggested that adjuvant chemotherapy confered minimal impact on overall survival or cancer specific survival in this group.However,performance statas and tumor stage were significant predictors of overall and cancer specific survival.